Mawer Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $68.3M | Sell |
|
|||||
|
2025
Q2 | $64.5M | Sell |
|
|||||
|
2025
Q1 | $71.8M | Buy |
|
|||||
|
2024
Q4 | $84.4M | Buy |
|
|||||
|
2024
Q3 | $72.9M | Buy |
|
|||||
|
2024
Q2 | $36.5M | Buy |
|
|||||
|
2024
Q1 | $46.1M | Buy |
|
|||||
|
2023
Q4 | $40M | Sell |
|
|||||
|
2023
Q3 | $58.4M | Buy |
|
|||||
|
2023
Q2 | $53.5M | Buy |
|
|||||
|
2023
Q1 | $46.5M | Buy |
|
|||||
|
2022
Q4 | $37.2M | Buy |
|
|||||
|
2022
Q3 | $29.1M | Buy |
|
|||||
|
2022
Q2 | $33.5M | Buy |
|
|||||
|
2022
Q1 | $22.9M | Buy |
|
|||||
|
2021
Q4 | $30.7M | Buy |
|
|||||
|
2021
Q3 | $30.1M | Sell |
|
|||||
|
2021
Q2 | $26M | Buy |
|
|||||
|
2021
Q1 | $23M | Buy |
|
|||||
|
2020
Q4 | $18.7M | Buy |
|